Hyperfine Sees FY2026 Sales $20.000M-$22.000M vs $18.000M Est

3/18/2026
Impact: 50
Healthcare

Hyperfine (NASDAQ: HYPR) has projected its FY2026 sales to be between $20.000 million and $22.000 million, surpassing the analyst estimate of $18.000 million. This indicates a positive outlook for the company's revenue growth in the upcoming fiscal year.

AI summary, not financial advice

Share: